PUBLISHER: The Business Research Company | PRODUCT CODE: 1946671
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946671
Oral syringes are medical devices designed to accurately measure and administer liquid medications orally, particularly for infants, children, or patients who have difficulty swallowing tablets or capsules. These syringes consist of a plunger and a clearly marked barrel, ensuring precise dosing without the need for a needle.
The primary types of oral syringes include clear oral syringes and colorful oral syringes. Clear oral syringes are transparent, graduated devices that allow for accurate measurement and clear visibility of liquid medications to ensure precise delivery. These syringes come in various capacities, including small, medium, and large volume options. They are commonly used in applications such as pediatric care, geriatric care, post-surgical or critical care, dental procedures, and other medical uses. End users of oral syringes include hospitals, clinics, home care settings, and other healthcare environments.
Tariffs have created moderate cost pressures in the oral syringes market by increasing prices of plastic resins, medical-grade polymers, and imported manufacturing equipment. These Tariffs are impacting production costs and pricing strategies, particularly affecting clear and colorful oral syringes across pediatric and home care segments, with asia-pacific and north america being the most affected regions due to high manufacturing and import dependency. Distribution channels such as online retail and pharmacy chains also face margin pressures. However, tariffs have encouraged local manufacturing, supplier diversification, and investments in domestic production, supporting long-term supply chain resilience.
The oral syringes market research report is one of a series of new reports from The Business Research Company that provides oral syringes market statistics, including oral syringes industry global market size, regional shares, competitors with a oral syringes market share, detailed oral syringes market segments, market trends and opportunities, and any further data you may need to thrive in the oral syringes industry. This oral syringes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The oral syringes market size has grown strongly in recent years. It will grow from $1.14 billion in 2025 to $1.22 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to growth in pediatric liquid medication usage, increasing hospital admissions, rising awareness of dosing errors, expansion of pharmaceutical liquid formulations, adoption of oral drug delivery systems.
The oral syringes market size is expected to see strong growth in the next few years. It will grow to $1.61 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to aging population growth, increase in home healthcare services, demand for safe needle-free administration, expansion of online pharmacy channels, innovation in ergonomic syringe design. Major trends in the forecast period include dose accuracy and medication safety focus, rising pediatric and geriatric medication demand, shift toward single-use and disposable devices, growth of home-based and self-administration care, customization of syringe design and capacity.
The growth of home healthcare is anticipated to drive the expansion of the oral syringes market in the coming years. Home healthcare includes medical and non-medical services delivered to individuals in their homes to aid recovery, manage chronic illnesses, or support overall health and independence. The expansion of home healthcare is largely attributed to the increasing prevalence of chronic diseases, as a growing number of patients require continuous, long-term care in convenient and cost-efficient home environments. Oral syringes facilitate home healthcare by allowing the safe, precise, and convenient administration of liquid medications, particularly for pediatric and elderly patients. For example, in October 2024, the U.S. Bureau of Labor Statistics, a US-based federal agency, reported that home- and community-based care accounted for 4.3 million jobs in 2024, supported by 2.5 million workers in services for older adults and individuals with disabilities and 1.8 million workers in home health care. Consequently, the expansion of home healthcare is contributing to the growth of the oral syringes market.
The growing prevalence of chronic diseases is expected to drive the expansion of the oral syringes market in the coming years. Chronic diseases are long-term medical conditions that generally develop gradually and persist for a year or longer, often requiring continuous medical care and restricting daily activities. The increasing incidence of chronic diseases is mainly attributed to unhealthy lifestyle factors such as poor nutrition, lack of physical activity, smoking, and excessive alcohol intake, all of which significantly raise the risk of developing long-term health conditions. Oral syringes aid in the management of chronic diseases by allowing accurate, safe, and consistent administration of liquid medications, particularly for patients undergoing long-term treatment. For example, in April 2025, the Centers for Disease Control and Prevention, a US-based organization responsible for safeguarding the nation's health, safety, and security through scientific research, reported that in 2023, 76.4% (approximately 194 million) of US adults had one or more chronic conditions, including 59.5% of young adults, 78.4% of midlife adults, and 93.0% of older adults. As a result, the rising prevalence of chronic diseases is contributing to the growth of the oral syringes market.
Key players in the oral syringes market are focusing on the development of innovative products, such as short-form syringes, to improve dosing precision while maintaining user-friendly designs. Short-form syringes are compact oral dosing devices engineered to deliver exact amounts of medication using a shorter barrel, which enhances ease of handling and administration. For example, in August 2024, Adelphi Healthcare Packaging, a pharmaceutical packaging firm based in the UK, introduced a new 1.5 ml short-form oral syringe as part of its expanded range of dosing pipettes. This compact syringe is tailored for accurate oral dosing and is suitable for both human and veterinary applications. It enables high-precision medication delivery in a small format and features an elm-end tip that prevents the attachment of luer connectors or needles, thereby reducing the risk of misuse for injections.
Major companies operating in the oral syringes market are Cardinal Health Inc., Medline Industries LP, Becton Dickinson And Company, Baxter International Inc., Terumo Corporation, Vygon SA, B. Braun Melsungen AG, Sol-Millennium Medical Group, CODAN Medizinische Gerate GmbH And Co KG, Changzhou Medical Appliances General Factory Co. Ltd., Neelkanth Polymer Industries Private Limited, Shako Flexipack Private Limited, Apex Medical Devices Private Limited, Vastmed LLC, Shanghai Kindly Enterprise Development Group Co. Ltd., Nipro Corporation, Hindustan Syringes And Medical Devices Limited, Weigao Group Medical Polymer Company Limited, JMS Co. Ltd., Narang Medical Limited
North America was the largest region in the oral syringes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral syringes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the oral syringes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The oral syringes market consists of sales of oral dispenser syringes with caps, oral syringes with bottle adapters, pre-filled oral syringes, and refillable oral syringes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Oral Syringes Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses oral syringes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for oral syringes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oral syringes market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.